Progyny Stock Forecast
NASDAQ: PGNYHealth CareMisc Health and Biotechnology ServicesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
PGNY analyst consensus
Consensus (12 analysts)
strong_buy
Avg. price target
$37.75+5.71%
- Strong buy 1
- Buy 9
- Hold 2
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
According to 12 Wall Street analysts covering Progyny (2026-11-22), 10 rate the stock a buy or strong buy, 2 rate it a hold and 0 rate it a sell or strong sell, for a consensus rating of "strong_buy". The average 12-month price target is $37.75, with a high estimate of $42.00 and a low estimate of $35.00. The average target implies upside of 5.7% from the current price of $35.71.
The spread between the highest and lowest targets is 20.0%, a relatively narrow range. Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for PGNY.
Summary generated from market data by MetaCap's automated system. Methodology
Rating distribution
| Rating | Analysts | Share |
|---|---|---|
| Strong buy | 1 | 8% |
| Buy | 9 | 75% |
| Hold | 2 | 17% |
| Sell | 0 | 0% |
| Strong sell | 0 | 0% |
Ratings as of 2026-11-22.
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $35.00 | -1.99% |
| Average target | $37.75 | +5.71% |
| High target | $42.00 | +17.61% |